BDBM329757 Preparation of (−)-2-[(4R)-6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]-N-(2-oxo-2,3-dihydro-1H-indol-5-yl)acetamide::US9663523, Example 21

SMILES Cc1nnc2n1-c1ccccc1C(c1ccc(Cl)cc1)=C[C@@H]2CC(=O)Nc1ccc2c(c1)CC(=O)N2

InChI Key InChIKey=HQHXROQNFTYBRD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329757   

TargetBromodomain-containing protein 4(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 329757BDBM329757(US9663523, Example 21 | Preparation of (−)-2...)
Affinity DataIC50: 80nMAssay Description:For this purpose, a time-resolved fluorescence resonance energy transfer (TR-FRET) assay was used, which measures the binding between N-terminally Hi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent